Betta Pharmaceuticals Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
177.04 | 69.4 | 155.11% | 0 | 0% |
| P/S |
|
8.6 | 6.51 | 32.16% |
|
|
| P/BV |
|
4.08 | 3.96 | 3.13% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
89.7 | 11.85 | 657.06% |
|
|
| Ev/S |
|
9.22 | 5.98 | 54.3% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0057 | 0.0396 | -85.6% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
14.47 | 20.39 | -29.05% | 27.68 | -47.74% |
| ROE |
|
1.91 | 11.95 | -84.01% |
|
|
| ROA |
|
0.6 | 5.4 | -88.89% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
4.88 | 16.23 | -69.94% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
6.02 | 14.63 | -58.85% | 4.64 | +29.62% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
17.86 | 3.6 | 396.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0.38/10
|
0.15 | 1.83 | -91.82% | 0.2665 | -43.7% |
| Number of years of dividend growth |
|
0 | 1.44 | -100% | ||
| DSI |
|
0.7857 | 0.9113 | -13.78% |
|
|
| Average dividend growth |
|
-14.66 | 10.4 | -240.99% |
|
|
| Average percentage for 5 years |
|
0.2665 | 1.14 | -76.67% |
|
|
| Average percentage for payments |
|
33.92 | 44.8 | -24.29% |
|
|
| Difference from average difference in sector |
|
-1.68 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
7/10
|
58.06 | 61.43 | -5.49% | ||
| Growth impulse Ebitda in 5 years |
|
75.08 | 158.62 | -52.67% | ||
| Growth impulse Net Income in 5 years |
|
50.78 | 66.93 | -24.13% | ||
| Growth impulse FCF in 5 years |
|
178.2 | 248.41 | -28.26% | ||
| Growth impulse EPS in 5 years |
|
-15.35 | 73.29 | -120.94% |
IP Score
4.28/10
